AR070307A1 - Extracto bacteriano para trastornos respiratorios y proceso para su preparacion - Google Patents

Extracto bacteriano para trastornos respiratorios y proceso para su preparacion

Info

Publication number
AR070307A1
AR070307A1 ARP080103705A ARP080103705A AR070307A1 AR 070307 A1 AR070307 A1 AR 070307A1 AR P080103705 A ARP080103705 A AR P080103705A AR P080103705 A ARP080103705 A AR P080103705A AR 070307 A1 AR070307 A1 AR 070307A1
Authority
AR
Argentina
Prior art keywords
extract
respiratory disorders
preparation
bacterial extract
present
Prior art date
Application number
ARP080103705A
Other languages
English (en)
Inventor
Alexander Bauer
Jean-Pierre Leon Vigroux
Laetitia Chalvet
Carlo Chiavaroli
Marco Salvagni
Original Assignee
Om Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Om Pharma filed Critical Om Pharma
Publication of AR070307A1 publication Critical patent/AR070307A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P39/00—Processes involving microorganisms of different genera in the same process, simultaneously
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invencion se refiere a un extracto a partir de cepas bacterianas, tales como Staphylococcus, Moraxella, Klebsiella, Streptococcus, y Haemophilus. El extracto es util como tratamiento para indicaciones tales como trastornos respiratorios, composiciones que comprenden el extracto, y procesos para preparar el extracto a partir de medios que no presentan un riesgo de enfermedad de priones.
ARP080103705A 2007-03-05 2008-08-26 Extracto bacteriano para trastornos respiratorios y proceso para su preparacion AR070307A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90478907P 2007-03-05 2007-03-05
PCT/US2008/055906 WO2008109669A2 (en) 2007-03-05 2008-03-05 Bacterial extract for respiratory disorders and proces for its preparation

Publications (1)

Publication Number Publication Date
AR070307A1 true AR070307A1 (es) 2010-03-31

Family

ID=39739087

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP080103705A AR070307A1 (es) 2007-03-05 2008-08-26 Extracto bacteriano para trastornos respiratorios y proceso para su preparacion
ARP180101407A AR111836A2 (es) 2007-03-05 2018-05-28 Extracto bacteriano para trastornos respiratorios

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP180101407A AR111836A2 (es) 2007-03-05 2018-05-28 Extracto bacteriano para trastornos respiratorios

Country Status (21)

Country Link
US (2) US8697154B2 (es)
EP (2) EP2114421B1 (es)
JP (1) JP5693010B2 (es)
KR (1) KR101527483B1 (es)
CN (1) CN101663041B (es)
AR (2) AR070307A1 (es)
AU (1) AU2008222865B2 (es)
BR (1) BRPI0808333B8 (es)
CA (1) CA2679843C (es)
DK (1) DK2114421T3 (es)
ES (1) ES2665002T3 (es)
HU (1) HUE038598T2 (es)
IL (1) IL200666A (es)
MX (1) MX2009009452A (es)
PL (1) PL2114421T3 (es)
PT (1) PT2114421T (es)
RU (1) RU2456007C2 (es)
SI (1) SI2114421T1 (es)
TW (1) TWI434693B (es)
WO (1) WO2008109669A2 (es)
ZA (1) ZA200906029B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0401876D0 (sv) * 2004-07-16 2004-07-16 Forskarpatent I Syd Ab Prevention of allergy in children
GB2477752A (en) * 2010-02-11 2011-08-17 Arab Biotechnology Company Detection of bacteria
FR2969658B1 (fr) * 2010-12-22 2014-10-17 Fabre Pierre Dermo Cosmetique Nouvelle bacterie et extraits de ladite bacterie et leur utilisation therapeutique
FR2969657B1 (fr) 2010-12-22 2014-02-07 Fabre Pierre Dermo Cosmetique Nouvelle bacterie et extraits de ladite bacterie et leur utilisation en dermatologie
CN103157108B (zh) * 2011-12-13 2016-01-20 宁云山 免疫调节剂组合物及其药物组合物和应用
AU2013217771A1 (en) * 2012-02-08 2014-08-28 Premune Ab Prevention of inflammatory disorders in domestic non-human mammals
WO2014164736A1 (en) * 2013-03-11 2014-10-09 University Of Florida Research Foundation, Incorporated Materials and methods for improving lung function and for prevention and/or treatment of radiation-induced lung complications
CN105779326A (zh) * 2014-12-25 2016-07-20 河南科技学院 化脓性链球菌细胞壁成分萃取方法
CN106310246A (zh) * 2016-08-31 2017-01-11 廖正芳 一种可吸入制剂及其制备方法
KR102134385B1 (ko) 2017-02-06 2020-07-16 주식회사 한국인삼공사 홍삼 추출물을 함유하는 호흡기 증상 개선용 조성물
US9795579B1 (en) * 2017-04-24 2017-10-24 Knoze Jr. Corporation Oral microbiota promoting method
CN108785251B (zh) * 2018-01-23 2020-11-24 盛元医药广州有限公司 一种眼用药物组合物及其制备方法和应用
EP3814496B1 (en) 2018-06-28 2023-11-22 Gen-Probe Incorporated Sample preparation method and system
CN113613665A (zh) * 2019-03-14 2021-11-05 Om药物公司 治疗和/或预防哮喘、哮喘恶化、过敏性哮喘和/或与呼吸系统病症相关的微生物群相关的病症的方法
KR20210141546A (ko) 2019-03-14 2021-11-23 옴 파르마 에스아 안정한 박테리아 추출물 제조 공정 및 이의 약제로서의 용도
JP7356742B2 (ja) * 2019-04-26 2023-10-05 エムディー ヘルスケア インコーポレイテッド ストレプトコッカスパイオジェネス細菌由来タンパク質及びその用途
KR102437436B1 (ko) 2019-04-26 2022-08-30 주식회사 엠디헬스케어 스트렙토코커스 파이오제네스 세균 유래 단백질 및 이의 용도

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3532790A (en) * 1968-02-23 1970-10-06 Canadian Patents Dev Somatic antigen vaccines from lysed inactivated bacteria and process for producing them
CH633188A5 (fr) * 1978-05-26 1982-11-30 Om Laboratoires Sa Medicament contre des maladies infectieuses des voies respiratoires.
IT1199301B (it) 1986-11-21 1988-12-30 Belfanti Ist Sieroterap Milan Lisato antigenico batterico,procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
CH685498A5 (fr) * 1992-02-14 1995-07-31 Om Lab Sa Extrait de macromolécules bactériennes, procédé pour sa préparation et composition pharmaceutique contenant cet extrait.
US5314822A (en) * 1992-10-15 1994-05-24 Merck & Co., Inc. Method of clonal growth of Streptococcus pneumoniae
GB9224584D0 (en) * 1992-11-23 1993-01-13 Connaught Lab Use of outer membrane protein d15 and its peptides as vaccine against haempohilus influenzae diseases
BR9408071A (pt) 1993-11-17 1996-12-24 Om Lab Sa Di-sacarideos de glucosamina processo para sua preparação e composição farmacêutica que compreende os mesmos e seu uso
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
WO1998054296A1 (en) 1997-05-28 1998-12-03 Chiron S.P.A. Culture medium with yeast or soy bean extract as aminoacid source and no protein complexes of animal origin
US20040087020A1 (en) * 1997-05-28 2004-05-06 Chiron S.P.A. Culture medium with yeast or soy bean extract as amino acid source and no protein complexes of animal origin
US20010051364A1 (en) * 1997-12-23 2001-12-13 Francis Michon Procedures for the extraction and isolation of bacterial capsular polysaccharides for use as vaccines or linked to proteins as conjugate vaccines
ES2346022T3 (es) 1997-12-23 2010-10-07 Baxter Healthcare S.A. Procedimiento para la extraccion y el aislamiento de polisacaridos capsulares bacterianos para su uso como vacunas o ligandos a proteinas como vacunas de conjugados.
JP2000319294A (ja) * 1999-05-11 2000-11-21 Asahi Chem Ind Co Ltd 生物由来高分子溶液精製方法
FR2822071B1 (fr) 2001-03-15 2005-07-01 Pf Medicament Utilisation d'une fraction membranaire de bacteries a gram negatif pour induire la maturation des cellules dendritiques
US20070020293A1 (en) * 2003-06-23 2007-01-25 Michon Francis J Vaccines against group neisseria meningitidis and meningococcal combinations thereof
CN1867258A (zh) * 2003-08-18 2006-11-22 生物平衡公司 一种稳定的液体益生组合物、其制备和应用
DE602005021924D1 (de) 2005-02-08 2010-07-29 Parmeggiani Francesco Verwendung eines bakterienlysats zur verhinderung eines tuberkuloserückfalls
WO2006084466A2 (en) * 2005-02-11 2006-08-17 Ace Biosciences A/S Surface-located streptococcus pneumoniae polypeptides
CA2556796C (en) * 2005-03-03 2018-01-23 Allergan, Inc. Animal product free system and process for purifying a botulinum toxin
JP4693839B2 (ja) * 2005-03-10 2011-06-01 共立製薬株式会社 動物由来の成分なしで培養可能である細胞株及びその作出方法、これを用いたウイルスの生産方法、及びワクチンの生産方法
JP5286089B2 (ja) 2006-01-13 2013-09-11 バクスター・インターナショナル・インコーポレイテッド ポリサッカライドを精製する方法
SI2117587T1 (en) * 2007-03-05 2018-04-30 Om Pharma Bacterial extract for disorders of the digestive or urinary tract and the process for its preparation

Also Published As

Publication number Publication date
TW200938212A (en) 2009-09-16
MX2009009452A (es) 2009-09-14
EP3332791A1 (en) 2018-06-13
CN101663041A (zh) 2010-03-03
CA2679843C (en) 2018-10-02
KR101527483B1 (ko) 2015-06-09
US9463209B2 (en) 2016-10-11
SI2114421T1 (en) 2018-04-30
KR20090122940A (ko) 2009-12-01
JP2010520302A (ja) 2010-06-10
EP2114421A2 (en) 2009-11-11
AR111836A2 (es) 2019-08-21
US20140205693A1 (en) 2014-07-24
BRPI0808333B1 (pt) 2020-03-10
JP5693010B2 (ja) 2015-04-01
AU2008222865A1 (en) 2008-09-12
ES2665002T3 (es) 2018-04-24
IL200666A0 (en) 2010-05-17
US20100227013A1 (en) 2010-09-09
US8697154B2 (en) 2014-04-15
RU2456007C2 (ru) 2012-07-20
DK2114421T3 (en) 2018-04-23
PT2114421T (pt) 2018-04-17
TWI434693B (zh) 2014-04-21
BRPI0808333B8 (pt) 2021-05-25
EP2114421B1 (en) 2018-01-10
RU2009136577A (ru) 2011-04-10
IL200666A (en) 2016-12-29
WO2008109669A3 (en) 2008-12-18
EP2114421A4 (en) 2010-09-22
PL2114421T3 (pl) 2018-07-31
CN101663041B (zh) 2012-05-23
HUE038598T2 (hu) 2018-10-29
BRPI0808333A2 (pt) 2017-05-30
WO2008109669A2 (en) 2008-09-12
ZA200906029B (en) 2010-11-24
AU2008222865B2 (en) 2013-01-31
CA2679843A1 (en) 2008-09-12

Similar Documents

Publication Publication Date Title
AR070307A1 (es) Extracto bacteriano para trastornos respiratorios y proceso para su preparacion
HK1258231A1 (zh) 治療阿爾茨海默氏症、亨廷頓氏症、孤獨症和其他障礙的方法
DOP2017000013A (es) Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
MX2011009369A (es) 2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
PH12015500211A1 (en) 4-methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalenes
UA113051C2 (xx) Гетероциклічні похідні та їх застосування у лікуванні неврологічних розладів
HK1136283A1 (en) Compounds for the prevention and treatment of cardiovascular diseases
MX340124B (es) Anticuerpos biespecificos.
WO2011069063A3 (en) Multicyclic compounds and methods of use thereof
WO2013033037A3 (en) Novel antiprion compounds
AR068348A1 (es) Extracto bacteriano para trastornos del tracto digestivo o urinario y proceso para su preparacion
CL2008000330A1 (es) Compuestos derivados de octahidro fenantreno sustituidos; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar asma, dermatitis, enfermedad de alzheimer, artritis, entre otras enfermedades.
TN2012000049A1 (en) Chromone derivatives a process for their preparation and their therapeutic application
MX2011008825A (es) 3-aminoisoxazolopiridinas sustituidas como moduladores de kcnq2/3.
WO2008153937A3 (en) Novel 1- heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments
MX2011008662A (es) 2-mercapto-3-aminopiridinas sustituidas como moduladores de kcnq2/3.
MX2011009338A (es) 3-amino-2-mercaptoquinolinas sustituidas como moduladores de kcnq2/3.
MX2010007810A (es) Coposicion que contiene capsicum para tratar un trastorno de la piel.
BR112014002859A2 (pt) purificação pós-processamento para produção de gama-butiro lactona
EP2542085A4 (en) COMPOUNDS FOR THE TREATMENT OF NEURODEEGENERATIVE DISORDER
BR112014000499A2 (pt) compostos de quinolona de aminometila
TN2011000531A1 (en) 5- alkynyl - pyridines
MX2014015340A (es) Composiciones y metodos para tratar o evitar infeccion por pneumovirus y enfermedades asociadas.
NZ603967A (en) 8-hydroxy-quinoline derivatives
BR112013005226A2 (pt) "n-fenetiltriazolonaacetamidas substituídas e o seu uso".

Legal Events

Date Code Title Description
FG Grant, registration